Brief: CytRx announces proposed public offering of common stock
20/07/2015 21:01
July 20 (Reuters) - CytRx Corp CYTR.O : * Announces proposed public offering of common stock * Intends to use the net proceeds of offering to fund clinical trials of drug candidate aldoxorubicin and drug discovery activities * Source text for Eikon ID:nPn8v48pB * Further company coverage CYTR.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on LadRx
See all newsBrief: Ladrx Issues 2024 Update To Shareholders
Brief: LadRx Completes Non-Dilutive Financing Transaction For Up To $11 Mln With Xoma Corporation
Brief: LadRx Intends To Apply To List Stock On Nasdaq Under Symbol 'LADX'
Brief: LadRx Announces Review Of Strategic Alternatives, Provides Corporate Updates
Brief: CytRx Highlights Orphazyme's Update On Productive Meeting With FDA Regarding Arimoclomol In Niemann-Pick Disease Type C